UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Targeted Nanomedicine for Cancer Therapeutics: Towards Precision Medicine Overcoming Drug Resistance

Drug resistance updates, 2017-03, Vol.31, p.15-30

2017

Volltextzugriff (PDF)

The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology

Drug resistance updates, 2020-12, Vol.53, p.100729, Article 100729

2020

Volltextzugriff (PDF)

The folate receptor as a rational therapeutic target for personalized cancer treatment

Drug resistance updates, 2014-10, Vol.17 (4), p.89-95

2014

Volltextzugriff (PDF)

Modulating ROS to overcome multidrug resistance in cancer

Drug resistance updates, 2018-11, Vol.41, p.1-25

2018

Volltextzugriff (PDF)

The multi-factorial nature of clinical multidrug resistance in cancer

Drug resistance updates, 2019-09, Vol.46, p.100645-100645, Article 100645

2019

Volltextzugriff (PDF)

Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance

Drug resistance updates, 2020-01, Vol.48, p.100663-100663, Article 100663

2020

Volltextzugriff (PDF)

Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach

Drug resistance updates, 2015-11, Vol.23, p.69-78

2015

Volltextzugriff (PDF)

Exploring Phytochemicals for Combating Antibiotic Resistance in Microbial Pathogens

Frontiers in pharmacology, 2021-07, Vol.12, p.720726-720726

2021

Volltextzugriff (PDF)

Genetic and Physiological Factors Affecting Human Milk Production and Composition

Nutrients, 2020-05, Vol.12 (5), p.1500

2020

Volltextzugriff (PDF)

MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: Current implications and future directions

Drug resistance updates, 2019-01, Vol.42, p.1-11

2019

Volltextzugriff (PDF)

Demonstrating aspects of multiscale modeling by studying the permeation pathway of the human ZnT2 zinc transporter

PLoS computational biology, 2018-11, Vol.14 (11), p.e1006503

2018

Volltextzugriff (PDF)

Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation

Drug resistance updates, 2016-01, Vol.24 (C), p.34-54

2016

Volltextzugriff (PDF)

Molecular basis of resistance to proteasome inhibitors in hematological malignancies

Drug resistance updates, 2015-01, Vol.18, p.18-35

2015

Volltextzugriff (PDF)

Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma

Drug resistance updates, 2022-03, Vol.61, p.100822-100822, Article 100822

2022

Volltextzugriff (PDF)

Targeted Nanoparticles Harboring Jasmine-Oil-Entrapped Paclitaxel for Elimination of Lung Cancer Cells

International journal of molecular sciences, 2021-01, Vol.22 (3), p.1019

2021

Volltextzugriff (PDF)

Lysosomes as mediators of drug resistance in cancer

Drug resistance updates, 2016-01, Vol.24, p.23-33

2016

Volltextzugriff (PDF)

Albumin and Hyaluronic Acid-Coated Superparamagnetic Iron Oxide Nanoparticles Loaded with Paclitaxel for Biomedical Applications

Molecules (Basel, Switzerland), 2017-06, Vol.22 (7), p.1030

2017

Volltextzugriff (PDF)

Folylpolyglutamate synthetase mRNA G-quadruplexes regulate its cell protrusion localization and enhance a cancer cell invasive phenotype upon folate repletion

BMC biology, 2023-02, Vol.21 (1), p.13-13, Article 13

2023

Volltextzugriff (PDF)

Beta-casein nanovehicles for oral delivery of chemotherapeutic drugs

Nanomedicine, 2010-02, Vol.6 (1), p.119-126

2010

Volltextzugriff (PDF)

Beta-casein Nanoparticles as an Oral Delivery System for Chemotherapeutic Drugs: Impact of Drug Structure and Properties on Co-assembly

Pharmaceutical research, 2010-10, Vol.27 (10), p.2175-2186

2010

Volltextzugriff (PDF)

A transcriptomic examination of encased rotifer embryos reveals the developmental trajectory leading to long-term dormancy; are they "animal seeds"?

BMC genomics, 2024-01, Vol.25 (1), p.119-119, Article 119

2024

Volltextzugriff (PDF)

Novel Selectively Targeted Multifunctional Nanostructured Lipid Carriers for Prostate Cancer Treatment

Pharmaceutics, 2021-12, Vol.14 (1), p.88

2021

Volltextzugriff (PDF)

Taxanes in cancer treatment: Activity, chemoresistance and its overcoming

Drug resistance updates, 2021-01, Vol.54, p.100742, Article 100742

2021

Volltextzugriff (PDF)

Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance

Neoplasia (New York, N.Y.), 2009-12, Vol.11 (12), p.1359,IN10-1370,IN11

2009

Volltextzugriff (PDF)

Rationally designed nanovehicles to overcome cancer chemoresistance

Advanced drug delivery reviews, 2013-11, Vol.65 (13-14), p.1716-1730

2013

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Aktive Filter

ThemaDrug Resistance

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(101)

Sprache

Englisch
(101)
Japanisch
(22)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Targeted Nanomedicine for Cancer Therapeutics: Towards Precision Medicine Overcoming Drug Resistance

The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology

The folate receptor as a rational therapeutic target for personalized cancer treatment

Modulating ROS to overcome multidrug resistance in cancer

The multi-factorial nature of clinical multidrug resistance in cancer

Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance

Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach

Exploring Phytochemicals for Combating Antibiotic Resistance in Microbial Pathogens

Genetic and Physiological Factors Affecting Human Milk Production and Composition

MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: Current implications and future directions

Demonstrating aspects of multiscale modeling by studying the permeation pathway of the human ZnT2 zinc transporter

Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation

Molecular basis of resistance to proteasome inhibitors in hematological malignancies

Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma

Targeted Nanoparticles Harboring Jasmine-Oil-Entrapped Paclitaxel for Elimination of Lung Cancer Cells

Lysosomes as mediators of drug resistance in cancer

Albumin and Hyaluronic Acid-Coated Superparamagnetic Iron Oxide Nanoparticles Loaded with Paclitaxel for Biomedical Applications

Folylpolyglutamate synthetase mRNA G-quadruplexes regulate its cell protrusion localization and enhance a cancer cell invasive phenotype upon folate repletion

Beta-casein nanovehicles for oral delivery of chemotherapeutic drugs

Beta-casein Nanoparticles as an Oral Delivery System for Chemotherapeutic Drugs: Impact of Drug Structure and Properties on Co-assembly

A transcriptomic examination of encased rotifer embryos reveals the developmental trajectory leading to long-term dormancy; are they "animal seeds"?

Novel Selectively Targeted Multifunctional Nanostructured Lipid Carriers for Prostate Cancer Treatment

Taxanes in cancer treatment: Activity, chemoresistance and its overcoming

Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance

Rationally designed nanovehicles to overcome cancer chemoresistance

Aktive Filter

Suchergebnisse filtern